BioNexus Gene Lab (BGLC) EBIT Margin (2018 - 2026)
BioNexus Gene Lab (BGLC) reported EBIT Margin of 2366.21% for Q1 2026, down 233727.0% on a YoY basis from N/an in Q1 2025, and down 1008.28% sequentially from 213.5% in Q4 2025.
BioNexus Gene Lab (BGLC) EBIT Margin (2018 - 2026) Analysis & Trends
BioNexus Gene Lab (BGLC) has 9 years of EBIT Margin data on file, last reported at 2366.21% in Q1 2026.
- For the quarter ending Q1 2026, EBIT Margin fell 233727.0% year-over-year to 2366.21%; the trailing twelve-month figure through Mar 2026 stood at 54.36% (down 3156.0% YoY), and the FY2025 full-year result was 39.93%, down 2339.0% from the prior year.
- EBIT Margin eased to 2366.21% in Q1 2026, from 213.5% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 13.13% in Q2 2024 to a low of 2366.21% in Q1 2026.
- A 5-year average of 166.62% and a median of 10.6% in 2023 frame the typical range for EBIT Margin.
- Across the five-year window, EBIT Margin jumped 4816 bps in 2024 and tumbled 233727 bps in 2026, its largest moves.
- Tracing BGLC's EBIT Margin over 5 years: stood at 4.32% in 2022, then jumped by 362 bps to 11.34% in 2023, then slumped by 245 bps to 16.49% in 2024, then sank by 1195 bps to 213.5% in 2025, then plunged by 1008 bps to 2366.21% in 2026.
- Business Quant data shows BGLC's EBIT Margin at 2366.21% in Q1 2026, 213.5% in Q4 2025, and 27.62% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Linde | 237.95 Bn | 233.99 Bn | 4.26 Bn | 27.78% |
| 2 | Sherwin Williams | 78.17 Bn | 77.95 Bn | 2.78 Bn | 14.31% |
| 3 | Ecolab | 76.02 Bn | 75.37 Bn | 1.85 Bn | 16.97% |
| 4 | Air Products & Chemicals | 66.38 Bn | 65.43 Bn | 987.40 Mn | 23.73% |
| 5 | Ppg Industries | 26.02 Bn | 24.40 Bn | 1.66 Bn | 16.72% |
| 6 | LyondellBasell Industries | 22.51 Bn | 19.87 Bn | 701.00 Mn | 3.32% |
| 7 | Chemical & Mining Co Of Chile | 19.70 Bn | 15.83 Bn | 778.60 Mn | 47.01% |
| 8 | International Flavors & Fragrances | 19.51 Bn | 18.95 Bn | 1.02 Bn | 9.96% |
| 9 | DuPont de Nemours | 18.80 Bn | 18.71 Bn | 602.00 Mn | 17.85% |
| 10 | BioNexus Gene Lab | 2.82 Mn | -1.14 Mn | -790.00 | -2,366.21% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,366.21% |
| Dec 31, 2025 | -213.50% |
| Sep 30, 2025 | -27.62% |
| Jun 30, 2025 | -27.05% |
| Mar 31, 2025 | -28.94% |
| Dec 31, 2024 | -16.49% |
| Sep 30, 2024 | -50.85% |
| Jun 30, 2024 | 13.13% |
| Mar 31, 2024 | -3.32% |
| Dec 31, 2023 | 11.34% |
| Sep 30, 2023 | -99.01% |
| Jun 30, 2023 | -10.60% |
| Mar 31, 2023 | -2.13% |
| Dec 31, 2022 | -4.32% |
| Sep 30, 2022 | -2.53% |
| Jun 30, 2022 | -5.55% |
| Mar 31, 2022 | 1.15% |
| Dec 31, 2021 | 6.20% |
| Sep 30, 2021 | 10.42% |
| Jun 30, 2021 | 4.53% |